Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W D Cash

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Ocular Pharmacology|January 1, 1986
Effects of topical diclofenac sodium in a rabbit model of ocular inflammation and leukotaxisJ M Rowland, C J Ford, R A Della Puca, et al.
Biochemical and Biophysical Research Communications|May 16, 1983
Characterization of imidazo[1,5-a]pyridine-5-hexanoic acid (CGS 13080) as a selective thromboxane synthetase inhibitor using in vitro and in vivo biochemical modelsE C Ku, S E McPherson, C Signor, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1987
Biochemical characterization of the triazoloquinazoline, CGS 15943, a novel, non-xanthine adenosine antagonistM Williams, J Francis, G Ghai, et al.
Journal of Medicinal Chemistry|May 1, 1988
Structure-activity profile of a series of novel triazoloquinazoline adenosine antagonistsJ E Francis, W D Cash, S Psychoyos, et al.
Life Sciences|January 25, 1982
CGS 8216: receptor binding characteristics of a potent benzodiazepine antagonistA J Czernik, B Petrack, H J Kalinsky, et al.
Journal of Medicinal Chemistry|January 1, 1991
Synthesis and benzodiazepine binding activity of a series of novel [1,2,4]triazolo[1,5-c]quinazolin-5(6H)-onesJ E Francis, W D Cash, B S Barbaz, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Ocular Pharmacology|January 1, 1986
Effects of topical diclofenac sodium in a rabbit model of ocular inflammation and leukotaxisJ M Rowland, C J Ford, R A Della Puca, et al.
Biochemical and Biophysical Research Communications|May 16, 1983
Characterization of imidazo[1,5-a]pyridine-5-hexanoic acid (CGS 13080) as a selective thromboxane synthetase inhibitor using in vitro and in vivo biochemical modelsE C Ku, S E McPherson, C Signor, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1987
Biochemical characterization of the triazoloquinazoline, CGS 15943, a novel, non-xanthine adenosine antagonistM Williams, J Francis, G Ghai, et al.
Journal of Medicinal Chemistry|May 1, 1988
Structure-activity profile of a series of novel triazoloquinazoline adenosine antagonistsJ E Francis, W D Cash, S Psychoyos, et al.
Life Sciences|January 25, 1982
CGS 8216: receptor binding characteristics of a potent benzodiazepine antagonistA J Czernik, B Petrack, H J Kalinsky, et al.
Journal of Medicinal Chemistry|January 1, 1991
Synthesis and benzodiazepine binding activity of a series of novel [1,2,4]triazolo[1,5-c]quinazolin-5(6H)-onesJ E Francis, W D Cash, B S Barbaz, et al.
Pageof 1